Richard Daniell, EVP, Europe Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 182,690 shares at $32.46 ($6.0M) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Seasonal sale ($6.0M) by EVP, Europe Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.46 | 20,461 | $664K | 11.1% |
| 2 | $32.46 | 33,512 | $1.1M | 18.2% |
| 3 | $32.46 | 20,461 | $664K | 11.1% |
| 4 | $32.46 | 33,512 | $1.1M | 18.2% |
| 5 | $32.95 | 37,372 | $1.2M | 20.6% |
| 6 | $32.95 | 37,372 |
| $1.2M |
| 20.6% |
| Total | $32.66 avg | 182,690 | $6.0M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |
| TEVA | SELL | 2025-03-07 | $2.3M | — | Filing → |